FT : Non-EU international students at UK universities less likely to get top gra

Non-EU international students at UK universities less likely to get top grades, data shows
Analysis will add to pressure on institutions accused of placing financial concerns ahead of academic quality

Students from outside the EU at universities in the UK are much less likely to obtain top grades than their British counterparts, according to data that will add to pressure on institutions accused of putting financial concerns ahead of academic quality.

A total of 28 per cent of non-EU international students received a lower-second (2.2) or third-class degree in 2021-22, compared with 20 per cent of domestic students, according to a Financial Times analysis of figures from the Higher Education Statistics Agency.

The findings come after funding pressures have left UK universities increasingly reliant on fees from international students — who on average pay about twice what domestic students pay each year — to balance the books. Fees from non-EU students now account for one-fifth of universities’ income, double what it was a decade ago.

The quality of the international student intake came under fresh scrutiny last month when Lord Jo Johnson, former Conservative universities minister, warned that rising numbers of foreign students were “reaching the political limits” of tolerance because too many were dropping out of courses or lacked the means to support themselves. He called for urgent action needed to “weed out” weak applicants.

According to the FT analysis, the attainment gap was largest at top universities, where international students are squeezing the number of places for Britons. Undergraduates from outside the EU enrolled at the research-intensive universities in the Russell Group were twice as likely as UK students to receive a 2.2 or third-class degree in 2021-22. 


The Russell Group said there was a “degree of adjustment” for international students and that universities had put in place a range of support to ease the transition. 

Some universities with large international intakes have a much larger attainment gap than the sector as a whole. At Queen’s University Belfast and the University of Sussex, the share of non-EU students obtaining the lowest grades in 2021-22 was more than three times higher than for UK students.

At Nottingham Trent University, more than half of non-EU students received a 2.2 or third, compared with a quarter of UK students.

Universities UK, the sector lobby group that represents more than 140 universities, said language barriers and different education systems partly explained the attainment gap. 

“The UK has a global reputation for the quality of education and rigorous quality assurance,” it said. “Universities are keenly aware of these challenges and provide a range of services to support their transition to studying in the UK. This is an area of ongoing research.”

Students from the EU perform better than other international students and in some cases better than UK students, but they make up a small proportion of the undergraduate intake. In 2021-22, more than 90 per cent of first-year international students came from outside the EU.


Students from China, India and other Asian countries are driving the rise in international student numbers. Dropout rates and non-completion for these students are bigger issues for the sector, according to Johnson.

“The real issue to focus on is the rising dropout rate of international students from India and Bangladesh,” he told the Financial Times. “It is essential universities and government forge a compact whereby all institutions will require tuition fees to be paid upfront.”

There is only a marginal difference in dropout rates for UK and international students, according to data from the Office for Students, England’s higher education regulator. A breakdown for specific countries is not available.


Nottingham Trent University said the discrepancy partly reflected its determination to root out the problem of grade inflation in higher education, for which it had been “widely recognised”.

“It is important to note that 2.2 is a good degree, and highly valued by employers both in the UK and abroad. For the skills-based recruiter, academic qualification levels are becoming less significant,” it added.

Sussex university said recent internal data pointed to a narrowing attainment gap between international and domestic students, but acknowledged that it could do more to ensure all students achieved their potential. 

“We’re working hard to continue this progress through greater investment in academic support, from intercultural awareness to further language support,” it added.

Queen’s University Belfast also said it was working hard to support international students and had recently put in place additional measures to help them succeed.

WSJ : Newmont Rethinks Future in Gold-Rush Era Town After $15 Billion Deal

Newmont Rethinks Future in Gold-Rush Era Town After $15 Billion Deal

ADELAIDE, Australia—The world’s biggest gold miner just got bigger. That has left a Colorado mine with its origins in the gold-rush era facing an uncertain future.

Newmont hasn’t NEM 2.79%increase; green up pointing triangle decided whether to sell the Cripple Creek & Victor gold mine following its $15 billion takeover of Australia’s Newcrest Mining NCM -1.27%decrease; red down pointing triangle, the largest transaction in gold-mining history. But Chief Executive Tom Palmer said the mine was smaller than many of the operations that Newmont now owns, and the company wants to raise some $2 billion from selling mines and rescheduling developments.

Cripple Creek “is certainly in that category of operations you debate around their fit,” Palmer said in an interview.

Mining has deep roots in Cripple Creek, located in Teller County, southwest of Pikes Peak. The town’s logo features a speculator with a pick leading a donkey. Residents can pitch up for coffee and food at the Gold Camp café. The local gold deposit, according to Newmont, was created by a volcanic eruption tens of millions of years ago.

Newmont, based in Denver, acquired the Cripple Creek mine from AngloGold Ashanti for $820 million eight years ago. It marked another step on Newmont’s road to building a business that outgrew rivals, including Barrick Gold, in terms of size.

The acquisition of Newcrest, which was completed on Monday and brings the company’s value to around $50 billion, advances that strategy still further. It adds five active mines and two advanced projects to Newmont’s existing global footprint.

But many of the mines that Newmont is getting as part of the Newcrest deal are richer in gold and cheaper to mine than Cripple Creek. Some also come with copious stores of copper, which Newmont increasingly wants to focus on, given its use in manufacturing electric vehicles and renewable-energy infrastructure.

Cripple Creek was once so rich with precious metal that it was nicknamed the world’s greatest gold camp. In the early 1900s, there were more than 500 mines worked by thousands of miners. That activity has left its mark on the area and its identity, but Palmer said it also means that much of the mine’s bounty has been dug up and the operation could struggle to compete inside Newmont with newer mines around the world.

Newmont produced 134,000 troy ounces of gold from Cripple Creek in the nine months through September. While that was 7% higher than a year earlier, the operation was one of the smallest contributors to overall output.

Still, there are reasons to hang on to the mine, said Palmer, a fourth-generation miner from the Australian mining town of Broken Hill.

“It’s literally an hour and a half up the road from headquarters,” Palmer said.

That means it could be a good learning ground for future mine managers and a testbed for new technologies, particularly as the company works to cut emissions from its operations, he said.

Cripple Creek isn’t alone in facing a debate about whether it belongs in the new Newmont.

There are also mines in Canada, Australia and Ghana whose futures will be scrutinized in the months ahead. No decisions have been made about those most likely to be sold, said Palmer.

“You may find that Newmont keeps a number of those in our portfolio over the long term because they’re generating good cash” and offer other benefits, Palmer said.

Part of the rationale for buying Newcrest was to strengthen Newmont’s footprint in favorable mining jurisdictions, he said, as a resurgence in resource nationalism becomes a problem again for the industry.

Executives will need to determine which operations can maintain sufficiently attractive profit margins, he said.

Already buyers are circling for some assets. Palmer said deal interest has been logged by Newmont’s corporate-development team of about 10 employees. That team managed a string of sales in-house after Newmont bought Goldcorp in 2019—bringing in close to $2 billion—and again might run deal negotiations without appointing an investment bank, he said.

“That team has a fairly full inbox,” said Palmer. “But they’re not under any pressure to be trying to get a quick sale out the door.”

FT : Steep falls in housebuilding drive contraction in UK construction

Steep falls in housebuilding drive contraction in UK construction
Recession fears mount as elevated interest rates take toll on economy, figures for October show

UK construction activity contracted in October, according to a data published on Monday, driven by the 11th consecutive monthly fall in housebuilding on the back of higher borrowing costs.

The S&P Global/Cips UK construction purchasing managers’ index rose slightly to 45.6 last month from 45 in September but remained below the 50 point mark, indicating that most businesses reported a contraction.

The reading, the second lowest since May 2020, was driven by a sharp contraction in housebuilding, which stood at 38.5. It also provides further evidence of the slowdown in demand sparked by higher interest rates.

Since November 2021, the Bank of England has raised rates from a record low of 0.1 per cent to 5.25 per cent in a push to bring inflation back to its 2 per cent target. As a result, activity in sectors that are sensitive to higher rates, such as housing, has weakened sharply.

Tim Moore, of S&P Global, said the survey’s results showed the impact of “elevated borrowing costs and a wait-and-see approach to new projects”.

Data last month from the Office for National Statistics, showed that construction output contracted in July and August, and Monday’s PMIs suggest the downturn has continued.


Thomas Pugh, economist at consulting group RSM UK, said: “The economy probably contracted in Q3 and, at face value, the PMIs are pointing to another contraction in Q4, which would mark the start of a recession.”

The latest S&P Global/Cips survey showed that new work in the construction sector fell for the third successive month in October, and that the rate of contraction was the joint sharpest since May 2020.

Many survey respondents reported a lack of tender opportunities and lengthier decision making among clients amid concerns about the broader economic outlook. The data for October also pointed to a slowdown in job creation to its weakest since June.

John Glen, Cips chief economist, said: “High interest rates and low consumer demand for new homes continue to drag down the UK construction sector, with a lack of new tender opportunities and a cutback of existing projects.”

In a sign that higher borrowing costs are having the effect the BoE intends, survey respondents also reported lower price pressure in October. Input prices in the sector fell at the fastest rate since August 2009, while the rates charged by subcontractors declined for the first time since July 2020.

Glen said that while suppliers were previously able to lift prices in response to soaring demand, “falling construction activity has now tilted the negotiations in favour of buyers and suppliers are having to pass on lower prices for raw materials like timber and steel”.

As demand has fallen, supply-side constraints have also continued to ease, with improved subcontractor availability and shortened suppliers’ delivery times.

Civil engineering activity was the second-worst performing sector, with a reading of 43.7, indicating the fastest rate of decline since July 2022.

Commercial building, meanwhile, showed signs of stabilisation, rising to 49.5 in October from 47.7 in September, indicating only a marginal fall in activity.

FT : From the US to Ukraine, the Gaza war will change the world

From the US to Ukraine, the Gaza war will change the world
Conflict in the Middle East is bad news for liberals and helpful for Putin and Trump

“Things can only get better” felt like the anthem for the 1990s. Released in 1993, four years after the fall of the Berlin wall, the song was the perfect soundtrack for a decade in which apartheid ended, democracy came to eastern Europe, peace came to Northern Ireland and the Oslo accords promised an end to the Israel-Palestine conflict.

In the 1990s, the spirit of the age favoured peacemakers, democrats and internationalists. Today, it is nationalists, warmongers and conspiracy theorists who have the wind in their sails.

There is a growing danger that Russia will gain the initiative in its war with Ukraine over the coming year. In the Middle East, the tentative optimism fostered by the Abraham peace accords between Israel and several Arab states has been shattered by the Hamas attacks and the Israeli invasion of Gaza. A wider Middle Eastern war currently looks more plausible than a reinvigorated peace process.

In the US, Joe Biden’s presidency is in deep trouble. Donald Trump is now the favourite in the betting markets to win the presidency in 2024. Recent polls show him comfortably ahead in most of the swing states that will decide the election.

All of these malign developments contribute to a darkening global political mood. They also feed on each other directly.

The Gaza war has forced the US to divert time and resources away from Ukraine. In some cases, there is direct competition for munitions. Ukraine has been desperately short of shells and now is competing with Israel for scarce supplies. Air defence systems are also needed by both Ukraine and Israel.

The west’s already weak ability to rally global support for Ukraine is further damaged by anger in the “Global South” about US support for Israel. Efforts to press the argument that Russia is committing war crimes in Ukraine will now be met with renewed charges of double standards.

These developments came at a time when the Ukrainian war effort was already faltering. The Kyiv government’s counteroffensive has largely failed.

Volodymyr Zelenskyy, Ukraine’s president, has angrily dismissed the idea that the war is turning into a stalemate. But predictions of a stalemate could actually prove over-optimistic. Russia has turned itself into a war economy and will probably have a growing edge in armaments and troop numbers next year. Russian forces are likely to hammer Ukrainian cities and infrastructure, once again, over the coming months.

A battered Ukraine remains heavily dependent on the west for armaments and financial support. But Kyiv’s western backers have failed to ramp up their weapons production to match the Russian war machine. Meanwhile, continued funding for Ukraine has got stuck in the US Congress as Trump-supporting Republicans turn against the war.

Vladimir Putin has even more reason to keep fighting hard over the next year, given the growing prospect that Donald Trump will return to the White House and abandon Ukraine to its fate.

A Trump victory has become more likely because of the Gaza conflict. Biden needs young voters, progressives and Arab-Americans to turn out and vote for him. But many are furious about his administration’s support for Israel. If progressives stay at home or vote for fringe candidates, the election could tip towards Trump.

Of course, it would be absurd if pro-Palestinian sentiment indirectly put Trump back into the White House. The former president is once again threatening to ban Muslims from entering the US. But history abounds with absurdities.

The intense global spotlight on Israel and Gaza may also be providing cover for other human rights abuses to take place. In recent weeks, mass deportations and forced transfers of people have either taken place or been announced in Pakistan, Sudan and Nagorno-Karabakh.

Other urgent problems are also in danger of being left to fester. Climate change looks ever more ominous. But the COP28 summit that will begin later this month in Dubai will now take place with world leaders distracted by Gaza.

With America overstretched overseas and unstable at home, China may sniff an opportunity. There are currently some tentative signs of rapprochement between Beijing and Washington. But the big picture remains that China is intent on displacing the US as the dominant power in the Pacific, and perhaps the world.

The main focus of Xi Jinping’s ambitions is Taiwan. Analysts in Washington believe that he has told the Chinese military to be ready to invade the island by 2027. In an effort to deter China, Biden has repeatedly pledged to defend Taiwan. But, with America distracted and divided, Xi may see an opportunity to increase the pressure on the island over the coming year. That would add a security crisis in east Asia to the ones gripping Europe and the Middle East.

In retrospect, it seems appropriate that “Things can only get better” was put out by a band called D:Ream. Thirty years after the song’s release, the dream is definitely over.

It is too fatalistic to say that we are now in an era when things can only get worse. But it is simple realism to understand that the strongest trends in world affairs are malign and gathering momentum.

>>> US Research Calls

Research Calls II
  • Upgrades:
    • ACADIA Pharmaceuticals (ACAD) upgraded to Buy from Neutral at Mizuho; tgt raised to $35
    • Bank of America (BAC) upgraded to Mkt Perform from Underperform at Keefe Bruyette; tgt raised to $30
    • Block (SQ) upgraded to Accumulate from Reduce at CLSA; tgt $57
    • Centerspace (CSR) upgraded to Buy from Neutral at Compass Point; tgt $65
    • Clorox (CLX) upgraded to Neutral from Sell at UBS; tgt raised to $132
    • Corcept Therapeutics (CORT) upgraded to Buy from Hold at Truist; tgt raised to $38
    • Dominion Energy (D) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $47
    • Entergy (ETR) upgraded to Buy from Neutral at UBS; tgt raised to $118
    • Ferrari (RACE) upgraded to Overweight from Equal Weight at Barclays
    • KeyCorp (KEY) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $15
    • Kontoor Brands (KTB) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $59
    • Park Hotels & Resorts (PK) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $19
    • Vermilion Energy (VET) upgraded to Buy from Hold at Desjardins
    • Visteon (VC) upgraded to Buy from Neutral at Citigroup; tgt $149
  • Downgrades:
    • Albemarle (ALB) downgraded to Neutral from Buy at UBS; tgt lowered to $140
    • Avient (AVNT) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $37
    • BJ's Wholesale (BJ) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $71
    • Bloomin' Brands (BLMN) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $28
    • Cathay Bancorp (CATY) downgraded to Underweight from Neutral at Piper Sandler; tgt $31
    • CF Industries (CF) downgraded to Sector Perform from Sector Outperform at Scotiabank
    • Enersys (ENS) downgraded to Mkt Perform from Outperform at William Blair
    • EngageSmart (ESMT) downgraded to Mkt Perform from Outperform at William Blair
    • Nutrien (NTR) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $58
    • Omega Health (OHI) downgraded to Underperform from Neutral at Exane BNP Paribas
    • Paramount Global (PARA) downgraded to Underperform from Buy at BofA Securities; tgt $9
    • SolarEdge Technologies (SEDG) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $82
    • TechnipFMC (FTI) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $23.50
  • Others:
    • Bilibili (BILI) initiated with a Buy at Mizuho; tgt $18
    • Birkenstock Holding Plc (BIRK) initiated with a Buy at Citigroup; tgt $52
    • Birkenstock Holding Plc (BIRK) initiated with a Buy at Deutsche Bank; tgt $43
    • Birkenstock Holding Plc (BIRK) initiated with a Buy at Goldman; tgt $48.50
    • Birkenstock Holding Plc (BIRK) initiated with a Buy at Stifel; tgt $47
    • Birkenstock Holding Plc (BIRK) initiated with a Hold at HSBC Securities; tgt $42
    • Birkenstock Holding Plc (BIRK) initiated with a Neutral at Exane BNP Paribas; tgt $44
    • Birkenstock Holding Plc (BIRK) initiated with a Neutral at UBS; tgt $44
    • Birkenstock Holding Plc (BIRK) initiated with an Equal-Weight at Morgan Stanley; tgt $41
    • Birkenstock Holding Plc (BIRK) initiated with an Outperform at BMO Capital Markets; tgt $50
    • Birkenstock Holding Plc (BIRK) initiated with an Outperform at Robert W. Baird; tgt $48
    • Birkenstock Holding Plc (BIRK) initiated with an Outperform at William Blair
    • Birkenstock Holding Plc (BIRK) initiated with an Overweight at JP Morgan; tgt $48
    • Birkenstock Holding Plc (BIRK) initiated with an Overweight at Piper Sandler; tgt $50
    • Confluent (CFLT) initiated with an Outperform at RBC Capital Mkts; tgt $22
    • CRH Plc. (CRH) initiated with a Neutral at Goldman; tgt $58
    • Legend Biotech (LEGN) initiated with a Buy at Goldman; tgt $90.09
    • UNITIL Corporation (UTL) initiated with a Neutral at Guggenheim
    • WK Kellogg Co (KLG) initiated with an Underweight at Barclays; tgt $11
    • World Kinect Corporation (WKC) initiated with an Equal-Weight at Morgan Stanley; tgt $24
    • WPP plc (WPP) resumed with an Equal-Weight at Morgan Stanley

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • KRYS +8.8%, FRPT +7.8%, AMG +4.7%, KNF +3.8%, AL +3.1%, BNTX +2.7%, UUUU +2.6%, ERJ +2.2%, CEG +2%, ACRS +2%, KOS +1.9%, HGV +1.3%, VVX +1.1%
Other news:
  • CLDX +26.1% (files mixed shelf securities offering; also Presents Positive Data from Prurigo Nodularis Phase 1b Study and topline results from barzolvolimab Phase 2 Study)
  • CRSP +5.5% (Announces Preclinical Data at the American Heart Association)
  • BTAI +5.2% (announced an update on the National Institute on Drug Abuse (NIDA)-funded trial evaluating BXCL501 (sublingual dexmedetomidine) as a potential treatment for opioid use disorder)
  • FSR +2.9% (promotes David King as its new Chief Technology Officer)
  • LUMN +2.7% (CEO bought 1000000 shares at $0.97 worth ~$970K)
  • VIR +2.6% (files mixed securities shelf offering)
  • HALO +2.6% (Halozyme Therapeutics and Acumen Pharmaceuticals (ABOS) announce global collaboration and non-exclusive license agreement for the ENHANZE Technology in Alzheimer's Disease)
  • TCRX +2.2% (Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting)
  • HUT +2.1% (reports Oct metrics)
  • RGNX +2% (Presents Positive One Year Data from Phase II ALTITUDE Trial of ABBV-RGX-314 for Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery)
  • CABA +1.9% (FDA clears CABA-201 a 4-1BB-containing fully human CD19-CAR T cell investigational therapy)
  • DNA +1.8% (Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens)
  • REPL +1.5% (Presents Updated Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy)
  • ALGN +1.2% (planning to repurchase $100 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program)
Analyst comments:
  • ACAD +3.5% (upgraded to Buy from Neutral at Mizuho)
  • KEY +2% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)
  • VC +1.4% (upgraded to Buy from Neutral at Citigroup)
  • SQ +1.3% (upgraded to Accumulate from Reduce at CLSA)
  • CLX +1.2% (upgraded to Neutral from Sell at UBS)
  • VET +1% (upgraded to Buy from Hold at Desjardins)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • TGLS -18.3%, DISH -6.6%, THS -0.7%
Other news:
  • KOD -8.1% (reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study)
  • ALPN -4.7% (commenced an underwritten public offering of $150 million of shares pursuant to its existing shelf registration statement)
  • MLTX -4.5% (announces landmark Phase 2 results for Nanobody sonelokimab)
  • PAC -2.5% (reports October traffic increased 4.7% yr/yr)
  • OVID -2% (files $250 mln mixed shelf securities offering)
  • APLS -1.9% (reports SYFOVRE (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 3 Years in Patients with Geographic Atrophy)
  • TRMB -1.2% (Trimble's Viewpoint Spectrum and Viewpoint Vista construction enterprise resource planning (ERP) software now includes Automatic Invoicing capability)
  • LGIH -1.1% (Oct closings)
  • CRBG -1.1% (AIG announces launch of secondary offering of Corebridge Financial (CRBG) common stock)
Analyst comments:
  • ALB -1.1% (downgraded to Neutral from Buy at UBS)

>>> Embraer SA reports Q3 (Sep) results, misses on revs; reaffirms outlook (15.1

Embraer SA reports Q3 (Sep) results, misses on revs; reaffirms outlook (15.15)
  • Reports Q3 (Sep) earnings of $0.38 per share, may not be comparable to the two analyst estimate of $0.24; revenues rose 38.1% year/year to $1.28 bln vs the $1.33 bln FactSet Consensus.
    • Firm order backlog ended 3Q23 at $17.8 billion, the highest level in one year, driven by higher sales in Commercial Aviation. Commercial Aviation backlog rose from $8 billion to $8.6 billion compared to 2Q23, with 42 aircraft sold in 2023. Services & Support reached $2.8 billion in the quarter, the highest volume ever recorded in the business unit. Executive Aviation strong backlog at $4.3 billion highlights its sustained demand backlog.
  • Operational and financial guidance for 2023 remains unchanged

>>> Constellation Energy beats by $0.78, misses on revs (117.07)

Constellation Energy beats by $0.78, misses on revs (117.07)
  • Reports Q3 (Sep) earnings of $2.26 per share, $0.78 better than the FactSet Consensus of $1.48; revenues rose 1.0% year/year to $6.11 bln vs the $7.01 bln FactSet Consensus.
  • Raising guidance range for full year 2023 Adjusted EBITDA (non-GAAP) to $3,800 million to $4,000 million.
  • "Our continued strong performance this quarter is the result of pairing the nation's largest clean energy fleet with an unmatched commercial business, allowing us to produce affordable and reliable carbon-free energy when and where American families and businesses need it," said Joe Dominguez, president and CEO of Constellation. "This combination of businesses is the fundamental strength of our strategy. It allows us to help customers like Microsoft and ComEd manage their energy costs in a volatile market, while also lowering their carbon emissions with clean energy matched to their use in every hour of every day. We continue to execute our growth strategy, closing on the South Texas Project transaction ahead of schedule and moving forward with $1.5 billion in growth spending on equipment to increase the output of our nuclear plants, wind repowering and pursuit of a nuclear-powered clean hydrogen facility as part of a multi-state hub."
  • "Our generation fleet performed at peak levels during a summer of record heat, while our commercial business continued to win new business and realize higher margins," said Dan Eggers, executive vice president and chief financial officer. "Our gross margin outlook for 2023 is now $850 million higher than our expectations at the start of the year and our outlook for 2024 has increased. Based on current market conditions and the continued strength of our operations, we are raising 2023 adjusted EBITDA guidance to a $3.9 billion mid-point and narrowing the range to $3.8 billion to $4 billion."